跳至主要内容
临床试验/NCT02617095
NCT02617095终止不适用

Comparison of the Efficacy and Safety of T2762 Versus Optive® in the Treatment of Moderate to Severe Dry Eye Syndrome

Laboratoires Thea2 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2015年2月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
64
试验地点
2
主要终点
Change of the symptomatology evaluation on a Visual Analogic Scale

研究概览

简要总结

The purpose of this study is to compare the efficacy and safety of T2762 versus Optive® in the treatment of moderate to severe Dry Eye Syndrome.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed and dated informed consent.
  • Male or female aged ≥ 18 years old.
  • Diagnosis of moderate to severe dry eye syndrome

排除标准

  • Pregnancy, lactation.
  • Childbearing potential woman who is not using a reliable method of contraception and is not surgically sterilised.
  • Inability of patient to understand the study procedures and thus inability to give informed consent.
  • Non-compliant patient
  • Participation in another clinical study at the same time as the present study.
  • Participation to the present study during the exclusion period of another clinical study.
  • Already included once in this study.
  • Ward of court.
  • Patient not covered by government health care scheme

结局指标

主要结局

Change of the symptomatology evaluation on a Visual Analogic Scale

时间窗: Day 28

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验